{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:26:22Z","timestamp":1793453182937,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070070"],"award-info":[{"award-number":["82070070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Idiopathic pulmonary fibrosis (IPF) is considered an age-related disease. Age-related changes, along with other factors such as obesity, hormonal imbalances, and various metabolic disorders, lead to ectopic fat deposition (EFD). This accumulation of fat outside of its normal storage sites is associated with detrimental effects such as lipotoxicity, oxidative stress, inflammation, and insulin resistance. This narrative review provides an overview of the connection between ectopic and visceral fat deposition in aging, obesity, and IPF. It also elucidates the mechanism by which ectopic fat deposition in the airways and lungs, pericardium, skeletal muscles, and pancreas contributes to lung injury and fibrosis in patients with IPF, directly or indirectly. Moreover, the review discusses the impact of EFD on the severity of the disease, quality of life, presence of comorbidities, and overall prognosis in IPF patients. The review provides detailed information on recent research regarding representative lipid-lowering drugs, hypoglycemic drugs, and lipid-targeting drugs in animal experiments and clinical studies. This may offer new therapeutic directions for patients with IPF.<\/jats:p>","DOI":"10.1186\/s12944-023-01964-3","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:02:29Z","timestamp":1700798549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoyun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Ann Rev Pathol. 2022;17:515\u201346. https:\/\/doi.org\/10.1146\/annurev-pathol-042320-030240.","journal-title":"Ann Rev Pathol"},{"key":"1964_CR2","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1038\/ncomms14532","volume":"8","author":"MJ Schafer","year":"2017","unstructured":"Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017;8:14532. https:\/\/doi.org\/10.1038\/ncomms14532.","journal-title":"Nat Commun"},{"key":"1964_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","volume":"40","author":"LE Leard","year":"2021","unstructured":"Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021;40:1349\u201379. https:\/\/doi.org\/10.1016\/j.healun.2021.07.005.","journal-title":"J Heart Lung Transplant"},{"key":"1964_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-physiol-021119-034610","volume":"82","author":"SJ Cho","year":"2020","unstructured":"Cho SJ, Stout-Delgado HW. Aging and lung disease. Ann Rev Physiol. 2020;82:433\u201359. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034610.","journal-title":"Ann Rev Physiol"},{"key":"1964_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41598-022-27269-6","volume":"13","author":"A Tylutka","year":"2023","unstructured":"Tylutka A, Morawin B, Walas \u0141, Micha\u0142ek M, Gwara A, Zembron-Lacny A. Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults. Sci Rep. 2023;13:89. https:\/\/doi.org\/10.1038\/s41598-022-27269-6.","journal-title":"Sci Rep"},{"key":"1964_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s42255-022-00590-0","volume":"4","author":"S Sugimoto","year":"2022","unstructured":"Sugimoto S, Mena HA, Sansbury BE, Kobayashi S, Tsuji T, Wang CH, et al. Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation. Nat Metab. 2022;4:775\u201390. https:\/\/doi.org\/10.1038\/s42255-022-00590-0.","journal-title":"Nat Metab"},{"key":"1964_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.chest.2021.05.002","volume":"160","author":"K Selvan","year":"2021","unstructured":"Selvan K, Adegunsoye A. The progression to interstitial lung disease: vicarious facts about visceral fat. Chest. 2021;160:400\u20132. https:\/\/doi.org\/10.1016\/j.chest.2021.05.002.","journal-title":"Chest"},{"key":"1964_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/s2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715\u201325. https:\/\/doi.org\/10.1016\/s2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1964_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10408363.2015.1041582","volume":"52","author":"S Laforest","year":"2015","unstructured":"Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Critical Rev Clin Lab Sci. 2015;52:301\u201313. https:\/\/doi.org\/10.3109\/10408363.2015.1041582.","journal-title":"Critical Rev Clin Lab Sci"},{"key":"1964_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ajcn.82.3.531","volume":"82","author":"M Visser","year":"2005","unstructured":"Visser M, Kritchevsky SB, Newman AB, Goodpaster BH, Tylavsky FA, Nevitt MC, et al. Lower serum albumin concentration and change in muscle mass: the health, aging and body composition study. Am J Clin Nutr. 2005;82:531\u20137. https:\/\/doi.org\/10.1093\/ajcn.82.3.531.","journal-title":"Am J Clin Nutr"},{"key":"1964_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13293-018-0189-3","volume":"9","author":"M Schorr","year":"2018","unstructured":"Schorr M, Dichtel LE, Gerweck AV, Valera RD, Torriani M, Miller KK, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018;9:28. https:\/\/doi.org\/10.1186\/s13293-018-0189-3.","journal-title":"Biol Sex Differ"},{"key":"1964_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/01902148.2013.829537","volume":"39","author":"XN Ge","year":"2013","unstructured":"Ge XN, Greenberg Y, Hosseinkhani MR, Long EK, Bahaie NS, Rao A, et al. High-fat diet promotes lung fibrosis and attenuates airway eosinophilia after exposure to cockroach allergen in mice. Exp Lung Res. 2013;39:365\u201378. https:\/\/doi.org\/10.3109\/01902148.2013.829537.","journal-title":"Exp Lung Res"},{"key":"1964_CR13","doi-asserted-by":"publisher","unstructured":"Elliot JG, Donovan GM, Wang KCW, Green FHY, James AL, Noble PB. Fatty airways: implications for obstructive disease. Eur Respir J. 2019;54.https:\/\/doi.org\/10.1183\/13993003.00857-2019.","DOI":"10.1183\/13993003.00857-2019"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00408-003-1048-4","volume":"182","author":"LS Inselman","year":"2004","unstructured":"Inselman LS, Chander A, Spitzer AR. Diminished lung compliance and elevated surfactant lipids and proteins in nutritionally obese young rats. Lung. 2004;182:101\u201317. https:\/\/doi.org\/10.1007\/s00408-003-1048-4.","journal-title":"Lung"},{"issue":"44","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41366-020-0647-y","volume":"2020","author":"R Ruze","year":"2005","unstructured":"Ruze R, Li J, Xu Q, Zhong M, Xiong Y, Yan Z, et al. Sleeve gastrectomy ameliorates alveolar structures and surfactant protein expression in lungs of obese and diabetic rats. Int J Obes. 2005;2020(44):2394\u2013404. https:\/\/doi.org\/10.1038\/s41366-020-0647-y.","journal-title":"Int J Obes"},{"key":"1964_CR16","doi-asserted-by":"publisher","first-page":"L392","DOI":"10.1152\/ajplung.00041.2009","volume":"298","author":"DJ Foster","year":"2010","unstructured":"Foster DJ, Ravikumar P, Bellotto DJ, Unger RH, Hsia CC. Fatty diabetic lung: altered alveolar structure and surfactant protein expression. Am J Physiol Lung Cell Mol Physiol. 2010;298:L392-403. https:\/\/doi.org\/10.1152\/ajplung.00041.2009.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1964_CR17","doi-asserted-by":"publisher","first-page":"645400","DOI":"10.3389\/fcell.2021.645400","volume":"9","author":"YQ Lv","year":"2021","unstructured":"Lv YQ, Dhlamini Q, Chen C, Li X, Bellusci S, Zhang JS. FGF10 and lipofibroblasts in lung homeostasis and disease: insights gained from the adipocytes. Front Cell Dev Biol. 2021;9:645400. https:\/\/doi.org\/10.3389\/fcell.2021.645400.","journal-title":"Front Cell Dev Biol."},{"key":"1964_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fgene.2018.00545","volume":"9","author":"J Wu","year":"2018","unstructured":"Wu J, Chu X, Chen C, Bellusci S. Role of fibroblast growth factor 10 in mesenchymal cell differentiation during lung development and disease. Front Genet. 2018;9:545. https:\/\/doi.org\/10.3389\/fgene.2018.00545.","journal-title":"Front Genet."},{"key":"1964_CR19","doi-asserted-by":"publisher","first-page":"L869","DOI":"10.1152\/ajplung.00109.2019","volume":"316","author":"SE McGowan","year":"2019","unstructured":"McGowan SE. The lipofibroblast: more than a lipid-storage depot. Am J Physiol Lung Cell Mol Physiol. 2019;316:L869-l71. https:\/\/doi.org\/10.1152\/ajplung.00109.2019.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1964_CR20","doi-asserted-by":"publisher","unstructured":"Rehan M, Deskin B, Kurundkar AR, Yadav S, Matsunaga Y, Manges J, et al. Nicotinamide N-methyltransferase Mediates Lipofibroblast-Myofibroblast Transition and Apoptosis Resistance. J Biol Chem. 2023:105027.https:\/\/doi.org\/10.1016\/j.jbc.2023.105027.","DOI":"10.1016\/j.jbc.2023.105027"},{"key":"1964_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.20945\/2359-3997000000313","volume":"65","author":"VB Chueire","year":"2021","unstructured":"Chueire VB, Muscelli E. Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect - a narrative review. Arch Endocrinol Metab. 2021;65:24\u201331. https:\/\/doi.org\/10.20945\/2359-3997000000313.","journal-title":"Arch Endocrinol Metab"},{"key":"1964_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1159\/000488824","volume":"46","author":"S Kochumon","year":"2018","unstructured":"Kochumon S, Wilson A, Chandy B, Shenouda S, Tuomilehto J, Sindhu S, et al. Palmitate Activates CCL4 Expression in Human Monocytic Cells via TLR4\/MyD88 Dependent Activation of NF-\u03baB\/MAPK\/ PI3K Signaling Systems. Cell Physiol Biochem. 2018;46:953\u201364. https:\/\/doi.org\/10.1159\/000488824.","journal-title":"Cell Physiol Biochem."},{"key":"1964_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1165\/rcmb.2018-0324OC","volume":"61","author":"SG Chu","year":"2019","unstructured":"Chu SG, Villalba JA, Liang X, Xiong K, Tsoyi K, Ith B, et al. Palmitic Acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress. Am J Respir Cell Mol Biol. 2019;61:737\u201346. https:\/\/doi.org\/10.1165\/rcmb.2018-0324OC.","journal-title":"Am J Respir Cell Mol Biol."},{"key":"1964_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1165\/rcmb.2014-0343OC","volume":"53","author":"F Romero","year":"2015","unstructured":"Romero F, Shah D, Duong M, Penn RB, Fessler MB, Madenspacher J, et al. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis. Am Respir Cell Mol Biol. 2015;53:74\u201386. https:\/\/doi.org\/10.1165\/rcmb.2014-0343OC.","journal-title":"Am Respir Cell Mol Biol"},{"key":"1964_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1165\/rcmb.2019-0098ED","volume":"61","author":"R Summer","year":"2019","unstructured":"Summer R, Mora AL. Lipid metabolism: a new player in the conundrum of lung fibrosis. Am J Respir Cell Mol Biol. 2019;61:669\u201370. https:\/\/doi.org\/10.1165\/rcmb.2019-0098ED.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1964_CR26","doi-asserted-by":"publisher","first-page":"6197219","DOI":"10.1155\/2022\/6197219","volume":"2022","author":"L Kou","year":"2022","unstructured":"Kou L, Kou P, Luo G, Wei S. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis. Oxid Med Cell Longev. 2022;2022:6197219. https:\/\/doi.org\/10.1155\/2022\/6197219.","journal-title":"Oxid Med Cell Longev"},{"key":"1964_CR27","doi-asserted-by":"publisher","unstructured":"Suryadevara V, Ramchandran R, Kamp DW, Natarajan V. Lipid mediators regulate pulmonary fibrosis: potential mechanisms and signaling pathways. Int J Mol Sci. 2020;21.https:\/\/doi.org\/10.3390\/ijms21124257.","DOI":"10.3390\/ijms21124257"},{"key":"1964_CR28","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1096\/fj.12-219634","volume":"27","author":"LS Huang","year":"2013","unstructured":"Huang LS, Berdyshev E, Mathew B, Fu P, Gorshkova IA, He D, et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB J. 2013;27:1749\u201360. https:\/\/doi.org\/10.1096\/fj.12-219634.","journal-title":"FASEB J"},{"key":"1964_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/thoraxjnl-2011-200026","volume":"67","author":"J Milara","year":"2012","unstructured":"Milara J, Navarro R, Juan G, Peir\u00f3 T, Serrano A, Ram\u00f3n M, et al. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax. 2012;67:147\u201356. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200026.","journal-title":"Thorax"},{"key":"1964_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1165\/rcmb.2007-0065OC","volume":"37","author":"Y Kono","year":"2007","unstructured":"Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, et al. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol. 2007;37:395\u2013404. https:\/\/doi.org\/10.1165\/rcmb.2007-0065OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1964_CR31","doi-asserted-by":"publisher","unstructured":"Huang LS, Sudhadevi T, Fu P, Punathil-Kannan PK, Ebenezer DL, Ramchandran R, et al. Sphingosine Kinase 1\/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo\/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts. Int J Mol Sci. 2020;21.https:\/\/doi.org\/10.3390\/ijms21062064.","DOI":"10.3390\/ijms21062064"},{"key":"1964_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, et al. Adipokines, adiposity, and atherosclerosis. Cell MolLife Sci. 2022;79:272. https:\/\/doi.org\/10.1007\/s00018-022-04286-2.","journal-title":"Cell MolLife Sci"},{"key":"1964_CR33","doi-asserted-by":"publisher","unstructured":"Becerril S, Rodr\u00edguez A, Catal\u00e1n V, Ram\u00edrez B, Mentxaka A, Neira G, et al. Sex- and Age-Dependent Changes in the Adiponectin\/Leptin Ratio in Experimental Diet-Induced Obesity in Mice. Nutrients. 2022;15.https:\/\/doi.org\/10.3390\/nu15010073.","DOI":"10.3390\/nu15010073"},{"key":"1964_CR34","doi-asserted-by":"publisher","first-page":"622468","DOI":"10.3389\/fimmu.2020.622468","volume":"11","author":"K Kiernan","year":"2020","unstructured":"Kiernan K, MacIver NJ. The role of the Adipokine leptin in immune cell function in health and disease. Front Immunol. 2020;11:622468. https:\/\/doi.org\/10.3389\/fimmu.2020.622468.","journal-title":"Front Immunol"},{"key":"1964_CR35","doi-asserted-by":"publisher","first-page":"17337","DOI":"10.1038\/s41598-021-96766-x","volume":"11","author":"MAR Brandao-Rangel","year":"2021","unstructured":"Brandao-Rangel MAR, Moraes-Ferreira R, Oliveira-Junior MC, Santos-Dias A, Bachi ALL, Gabriela-Pereira G, et al. Pulmonary function changes in older adults with and without metabolic syndrome. Sci Rep. 2021;11:17337. https:\/\/doi.org\/10.1038\/s41598-021-96766-x.","journal-title":"Sci Rep"},{"key":"1964_CR36","doi-asserted-by":"publisher","first-page":"151997","DOI":"10.1016\/j.imbio.2020.151997","volume":"225","author":"M d'Alessandro","year":"2020","unstructured":"d\u2019Alessandro M, Bergantini L, Refini RM, Cameli P, Perillo F, Landi C, et al. Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment. Immunobiology. 2020;225:151997. https:\/\/doi.org\/10.1016\/j.imbio.2020.151997.","journal-title":"Immunobiology"},{"key":"1964_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1165\/rcmb.2020-0086OC","volume":"64","author":"H Han","year":"2021","unstructured":"Han H, Chung SI, Park HJ, Oh EY, Kim SR, Park KH, et al. Obesity-induced vitamin D deficiency contributes to lung fibrosis and airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2021;64:357\u201367. https:\/\/doi.org\/10.1165\/rcmb.2020-0086OC.","journal-title":"Am J Respir Cell Mol Biol."},{"key":"1964_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","volume":"18","author":"X Unamuno","year":"2021","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Ram\u00edrez B, Rodr\u00edguez A, Becerril S, Valent\u00ed V, et al. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. Cell Mol Immunol. 2021;18:1045\u201357. https:\/\/doi.org\/10.1038\/s41423-019-0296-z.","journal-title":"Cell Mol Immunol"},{"key":"1964_CR39","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2007.02.011","volume":"119","author":"X Zhou","year":"2007","unstructured":"Zhou X, Hu H, Huynh ML, Kotaru C, Balzar S, Trudeau JB, et al. Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts. J Allergy Clin Immunol. 2007;119:1388\u201397. https:\/\/doi.org\/10.1016\/j.jaci.2007.02.011.","journal-title":"J Allergy Clin Immunol."},{"key":"1964_CR40","doi-asserted-by":"publisher","unstructured":"Lee JJ, Britton KA, Pedley A, Massaro JM, Speliotes EK, Murabito JM, et al. Adipose Tissue Depots and Their Cross-Sectional Associations With Circulating Biomarkers of Metabolic Regulation. J Am Heart Assoc. 2016;5.https:\/\/doi.org\/10.1161\/jaha.115.002936.","DOI":"10.1161\/jaha.115.002936"},{"key":"1964_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1183\/13993003.00564-2015","volume":"47","author":"I Lasithiotaki","year":"2016","unstructured":"Lasithiotaki I, Giannarakis I, Tsitoura E, Samara KD, Margaritopoulos GA, Choulaki C, et al. NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung. Eur Respir J. 2016;47:910\u20138. https:\/\/doi.org\/10.1183\/13993003.00564-2015.","journal-title":"Eur Respir J"},{"key":"1964_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/bph.15277","volume":"178","author":"W Qiu","year":"2021","unstructured":"Qiu W, Wu H, Hu Z, Wu X, Tu M, Fang F, et al. Identification and characterization of a novel adiponectin receptor agonist adipo anti-inflammation agonist and its anti-inflammatory effects in vitro and in vivo. Br J Pharmacol. 2021;178:280\u201397. https:\/\/doi.org\/10.1111\/bph.15277.","journal-title":"Br J Pharmacol"},{"key":"1964_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ki.2010.391","volume":"79","author":"L Yvan-Charvet","year":"2011","unstructured":"Yvan-Charvet L, Quignard-Boulang\u00e9 A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 2011;79:162\u20138. https:\/\/doi.org\/10.1038\/ki.2010.391.","journal-title":"Kidney Int"},{"key":"1964_CR44","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.metabol.2009.11.016","volume":"59","author":"S Okada","year":"2010","unstructured":"Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T, et al. Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism. 2010;59:1241\u201351. https:\/\/doi.org\/10.1016\/j.metabol.2009.11.016.","journal-title":"Metabolism"},{"key":"1964_CR45","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.jnutbio.2013.07.002","volume":"24","author":"ME Frigolet","year":"2013","unstructured":"Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem. 2013;24:2003\u201315. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.07.002.","journal-title":"J Nutr Biochem"},{"key":"1964_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00004872-199917040-00014","volume":"17","author":"S Engeli","year":"1999","unstructured":"Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertension. 1999;17:555\u201360. https:\/\/doi.org\/10.1097\/00004872-199917040-00014.","journal-title":"J Hypertension"},{"key":"1964_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","volume":"40","author":"WSD Tan","year":"2018","unstructured":"Tan WSD, Liao W, Zhou S, Mei D, Wong WF. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2018;40:9\u201317. https:\/\/doi.org\/10.1016\/j.coph.2017.12.002.","journal-title":"Curr Opin Pharmacol"},{"key":"1964_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1183\/09031936.00130310","volume":"39","author":"E Montes","year":"2012","unstructured":"Montes E, Ruiz V, Checa M, Maldonado V, Melendez-Zajgla J, Monta\u00f1o M, et al. Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis. Eur Respir J. 2012;39:141\u20138. https:\/\/doi.org\/10.1183\/09031936.00130310.","journal-title":"Eur Respir J"},{"key":"1964_CR49","doi-asserted-by":"publisher","first-page":"15561","DOI":"10.1038\/srep15561","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Chen L, Chen B, Meliton A, Liu SQ, Shi Y, et al. Chronic activation of the renin-angiotensin system induces lung fibrosis. Sci Rep. 2015;5:15561. https:\/\/doi.org\/10.1038\/srep15561.","journal-title":"Sci Rep"},{"key":"1964_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.15406\/jlprr.2018.05.00191","volume":"5","author":"X Li","year":"2018","unstructured":"Li X, Zhuang J, Uhal BD. Local activation of the pulmonary extravascular angiotensin system induces epithelial apoptosis and lung fibrosis. J Lung Pulmonary Respir Res. 2018;5:192\u2013200. https:\/\/doi.org\/10.15406\/jlprr.2018.05.00191.","journal-title":"J Lung Pulmonary Respir Res"},{"key":"1964_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1055\/s-2001-14948","volume":"33","author":"T Skurk","year":"2001","unstructured":"Skurk T, Lee YM, R\u00f6hrig K, Hauner H. Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes. Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2001;33:196\u2013200. https:\/\/doi.org\/10.1055\/s-2001-14948.","journal-title":"Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"1964_CR52","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1182\/blood-2010-12-324574","volume":"118","author":"AJ Courey","year":"2011","unstructured":"Courey AJ, Horowitz JC, Kim KK, Koh TJ, Novak ML, Subbotina N, et al. The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. Blood. 2011;118:2313\u201321. https:\/\/doi.org\/10.1182\/blood-2010-12-324574.","journal-title":"Blood"},{"key":"1964_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","volume":"62","author":"T Rana","year":"2020","unstructured":"Rana T, Jiang C, Liu G, Miyata T, Antony V, Thannickal VJ, et al. PAI-1 Regulation of TGF-\u03b21-induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages. Am J Respir Cell Mol Biol. 2020;62:319\u201330. https:\/\/doi.org\/10.1165\/rcmb.2019-0071OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1964_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0258-7","volume":"51","author":"YH Park","year":"2019","unstructured":"Park YH, Oh EY, Han H, Yang M, Park HJ, Park KH, et al. Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-\u03b21 pathway. ExpMol Med. 2019;51:1\u201312. https:\/\/doi.org\/10.1038\/s12276-019-0258-7.","journal-title":"ExpMol Med"},{"key":"1964_CR55","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1161\/01.Cir.0000150391.38660.9b","volume":"110","author":"U Salmenniemi","year":"2004","unstructured":"Salmenniemi U, Ruotsalainen E, Pihlajam\u00e4ki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;110:3842\u20138. https:\/\/doi.org\/10.1161\/01.Cir.0000150391.38660.9b.","journal-title":"Circulation"},{"key":"1964_CR56","doi-asserted-by":"publisher","first-page":"e2100220","DOI":"10.1002\/mnfr.202100220","volume":"65","author":"T Zhu","year":"2021","unstructured":"Zhu T, Zhao J, Zhuo S, Hu Z, Ouyang S, Wunier, et al. High Fat Diet and High Cholesterol Diet Reduce Hepatic Vitamin D-25-Hydroxylase Expression and Serum 25-Hydroxyvitamin D(3) Level through Elevating Circulating Cholesterol, Glucose, and Insulin Levels. Mol Nutr Food Res. 2021;65:e2100220. https:\/\/doi.org\/10.1002\/mnfr.202100220.","journal-title":"Mol Nutr Food Res"},{"key":"1964_CR57","doi-asserted-by":"publisher","first-page":"785117","DOI":"10.3389\/fphys.2021.785117","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Yi X, Tang D. Aerobic exercise improves pulmonary fibrosis by improving insulin resistance and inflammation in obese mice. Front Physiol. 2021;12:785117. https:\/\/doi.org\/10.3389\/fphys.2021.785117.","journal-title":"Front Physiol"},{"key":"1964_CR58","first-page":"2144","volume":"20","author":"L Rong","year":"2016","unstructured":"Rong L, Wu J, Wang W, Zhao RP, Xu XW, Hu D. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT). Eur Rev Med Pharmacol Sci. 2016;20:2144\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1964_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1600-0404.1987.tb07907.x","volume":"75","author":"AS David","year":"1987","unstructured":"David AS, Jeste DV, Folstein MF, Folstein SE. Voluntary movement dysfunction in Huntington\u2019s disease and tardive dyskinesia. Acta neurologica Scandinavica. 1987;75:130\u20139. https:\/\/doi.org\/10.1111\/j.1600-0404.1987.tb07907.x.","journal-title":"Acta neurologica Scandinavica"},{"key":"1964_CR60","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.exger.2020.111162","volume":"143","author":"M Zamboni","year":"2021","unstructured":"Zamboni M, Nori N, Brunelli A, Zoico E. How does adipose tissue contribute to inflammageing? Exp Gerontol. 2021;143:111162. https:\/\/doi.org\/10.1016\/j.exger.2020.111162.","journal-title":"Exp Gerontol"},{"key":"1964_CR61","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1194\/jlr.M079665","volume":"59","author":"P Kotzbeck","year":"2018","unstructured":"Kotzbeck P, Giordano A, Mondini E, Murano I, Severi I, Venema W, et al. Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation. J Lipid Res. 2018;59:784\u201394. https:\/\/doi.org\/10.1194\/jlr.M079665.","journal-title":"J Lipid Res"},{"key":"1964_CR62","doi-asserted-by":"publisher","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci. 2019; 20.https:\/\/doi.org\/10.3390\/ijms20092358.","DOI":"10.3390\/ijms20092358"},{"key":"1964_CR63","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.4049\/jimmunol.1102188","volume":"187","author":"CN Lumeng","year":"2011","unstructured":"Lumeng CN, Liu J, Geletka L, Delaney C, Delproposto J, Desai A, et al. Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol (Baltimore, Md\u202f: 1950). 2011;187:6208\u201316. https:\/\/doi.org\/10.4049\/jimmunol.1102188.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"1964_CR64","doi-asserted-by":"publisher","first-page":"E1782","DOI":"10.1210\/jc.2011-1577","volume":"96","author":"AA Bremer","year":"2011","unstructured":"Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96:E1782-8. https:\/\/doi.org\/10.1210\/jc.2011-1577.","journal-title":"J Clin Endocrinol Metab"},{"key":"1964_CR65","doi-asserted-by":"publisher","unstructured":"Bergantini L, d'Alessandro M, Gangi S, Bianchi F, Cameli P, Perea B, et al. Predictive role of cytokine and adipokine panel in hospitalized COVID-19 patients: evaluation of disease severity, survival and lung sequelae. Int J Mol Sci. 2023;24.https:\/\/doi.org\/10.3390\/ijms241612994.","DOI":"10.3390\/ijms241612994"},{"key":"1964_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, et al. An aged immune system drives senescence and ageing of solid organs. Nature. 2021;594:100\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03547-7.","journal-title":"Nature"},{"key":"1964_CR67","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914\u201320. https:\/\/doi.org\/10.1038\/nm.1964.","journal-title":"Nat Med"},{"key":"1964_CR68","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s00125-011-2103-y","volume":"54","author":"RW O'Rourke","year":"2011","unstructured":"O\u2019Rourke RW, White AE, Metcalf MD, Olivas AS, Mitra P, Larison WG, et al. Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia. 2011;54:1480\u201390. https:\/\/doi.org\/10.1007\/s00125-011-2103-y.","journal-title":"Diabetologia"},{"key":"1964_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12931-018-0728-9","volume":"19","author":"J Milara","year":"2018","unstructured":"Milara J, Hernandez G, Ballester B, Morell A, Roger I, Montero P, et al. The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Respir Res. 2018;19:24. https:\/\/doi.org\/10.1186\/s12931-018-0728-9.","journal-title":"Respir Res"},{"key":"1964_CR70","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","volume":"99","author":"S Bolourani","year":"2021","unstructured":"Bolourani S, Brenner M, Wang P. The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis. J Mol Med (Berlin, Germany). 2021;99:1373\u201384. https:\/\/doi.org\/10.1007\/s00109-021-02113-y.","journal-title":"J Mol Med (Berlin, Germany)"},{"key":"1964_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","volume":"55","author":"S Kolahian","year":"2016","unstructured":"Kolahian S, Fernandez IE, Eickelberg O, Hartl D. Immune Mechanisms in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2016;55:309\u201322. https:\/\/doi.org\/10.1165\/rcmb.2016-0121TR.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1964_CR72","doi-asserted-by":"publisher","first-page":"e0255365","DOI":"10.1371\/journal.pone.0255365","volume":"16","author":"JH Lee","year":"2021","unstructured":"Lee JH, Jang JH, Park JH, Jang HJ, Park CS, Lee S, et al. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases. PloS One. 2021;16:e0255365. https:\/\/doi.org\/10.1371\/journal.pone.0255365.","journal-title":"PloS One"},{"key":"1964_CR73","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1111\/jcmm.15475","volume":"24","author":"LH Cong","year":"2020","unstructured":"Cong LH, Li T, Wang H, Wu YN, Wang SP, Zhao YY, et al. IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K\/Akt\/mTOR-mediated autophagy. J Cell Mol Med. 2020;24:8532\u201344. https:\/\/doi.org\/10.1111\/jcmm.15475.","journal-title":"J Cell Mol Med"},{"key":"1964_CR74","doi-asserted-by":"publisher","first-page":"L127","DOI":"10.1152\/ajplung.00200.2017","volume":"314","author":"L Yang","year":"2018","unstructured":"Yang L, Herrera J, Gilbertsen A, Xia H, Smith K, Benyumov A, et al. IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. AmJ Physiol Lung Cell Molecular Physiol. 2018;314:L127-l36. https:\/\/doi.org\/10.1152\/ajplung.00200.2017.","journal-title":"AmJ Physiol Lung Cell Molecular Physiol"},{"key":"1964_CR75","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.chest.2021.03.058","volume":"160","author":"MR Anderson","year":"2021","unstructured":"Anderson MR, Kim JS, Allison M, Giles JT, Hoffman EA, Ding J, et al. Adiposity and interstitial lung abnormalities in community-dwelling adults: The MESA cohort study. Chest. 2021;160:582\u201394. https:\/\/doi.org\/10.1016\/j.chest.2021.03.058.","journal-title":"Chest"},{"key":"1964_CR76","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00408-020-00386-7","volume":"198","author":"A Zinellu","year":"2020","unstructured":"Zinellu A, Paliogiannis P, Sotgiu E, Mellino S, Mangoni AA, Zinellu E, et al. Blood cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis. Lung. 2020;198:821\u20137. https:\/\/doi.org\/10.1007\/s00408-020-00386-7.","journal-title":"Lung."},{"key":"1964_CR77","doi-asserted-by":"publisher","first-page":"e0207284","DOI":"10.1371\/journal.pone.0207284","volume":"13","author":"KT Sung","year":"2018","unstructured":"Sung KT, Kuo R, Sun JY, Hung TC, Chang SC, Liu CC, et al. Associations between CT-determined visceral fat burden, hepatic steatosis, circulating white blood cell counts and neutrophil-to-lymphocyte ratio. PloS One. 2018;13:e0207284. https:\/\/doi.org\/10.1371\/journal.pone.0207284.","journal-title":"PloS One"},{"key":"1964_CR78","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.celrep.2019.03.038","volume":"27","author":"A Girousse","year":"2019","unstructured":"Girousse A, Gil-Ortega M, Bourlier V, Bergeaud C, Sastourn\u00e9-Arrey Q, Moro C, et al. The Release of adipose stromal cells from subcutaneous adipose tissue regulates ectopic intramuscular adipocyte deposition. Cell Rep. 2019;27:323-33.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.038.","journal-title":"Cell Rep"},{"key":"1964_CR79","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1016\/j.clnu.2020.01.001","volume":"39","author":"J Grillot","year":"2020","unstructured":"Grillot J, D\u2019Engremont C, Parmentier AL, Lakkis Z, Piton G, Cazaux D, et al. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn\u2019s disease. Clin Nutr (Edinburgh, Scotland). 2020;39:3024\u201330. https:\/\/doi.org\/10.1016\/j.clnu.2020.01.001.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"Suppl 2","key":"1964_CR80","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1016\/j.acra.2021.07.020","volume":"29","author":"C Jalaber","year":"2022","unstructured":"Jalaber C, Lemerre-Poincloux J, Jouneau S, Rousseau C, Dolou B, Rouag E, et al. Usefulness of body composition CT analysis in patients with idiopathic pulmonary fibrosis: a pilot study. Acad Radiol. 2022;29(Suppl 2):S191-s201. https:\/\/doi.org\/10.1016\/j.acra.2021.07.020.","journal-title":"Acad Radiol"},{"key":"1964_CR81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jcsm.12901","volume":"13","author":"CW Li","year":"2022","unstructured":"Li CW, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13:781\u201394. https:\/\/doi.org\/10.1002\/jcsm.12901.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1964_CR82","doi-asserted-by":"publisher","unstructured":"Knudsen JR, Persson KW, Henriquez-Olguin C, Li Z, Di Leo N, Hesselager SA, et al. Microtubule-mediated GLUT4 trafficking is disrupted in insulin-resistant skeletal muscle. eLife. 2023;12.https:\/\/doi.org\/10.7554\/eLife.83338.","DOI":"10.7554\/eLife.83338"},{"key":"1964_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179\u201388. https:\/\/doi.org\/10.1038\/nm.2279.","journal-title":"Nat Med"},{"key":"1964_CR84","doi-asserted-by":"publisher","first-page":"e13197","DOI":"10.1111\/cpr.13197","volume":"55","author":"S Ma","year":"2022","unstructured":"Ma S, Shyh-Chang N. The Metabaging Cycle. Cell Prolif. 2022;55:e13197. https:\/\/doi.org\/10.1111\/cpr.13197.","journal-title":"Cell Prolif"},{"key":"1964_CR85","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1111\/febs.16080","volume":"289","author":"G Giuliani","year":"2022","unstructured":"Giuliani G, Rosina M, Reggio A. Signaling pathways regulating the fate of fibro\/adipogenic progenitors (FAPs) in skeletal muscle regeneration and disease. FEBS J. 2022;289:6484\u2013517. https:\/\/doi.org\/10.1111\/febs.16080.","journal-title":"FEBS J"},{"key":"1964_CR86","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1038\/s41467-019-10438-z","volume":"10","author":"MW Hogarth","year":"2019","unstructured":"Hogarth MW, Defour A, Lazarski C, Gallardo E, Diaz Manera J, Partridge TA, et al. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat Commun. 2019;10:2430. https:\/\/doi.org\/10.1038\/s41467-019-10438-z.","journal-title":"Nat Commun"},{"key":"1964_CR87","doi-asserted-by":"publisher","first-page":"H1164","DOI":"10.1152\/ajpheart.00831.2015","volume":"310","author":"T Sente","year":"2016","unstructured":"Sente T, Van Berendoncks AM, Fransen E, Vrints CJ, Hoymans VY. Tumor necrosis factor-\u03b1 impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures. Am J physiol Heart Circ Physiol. 2016;310:H1164-75. https:\/\/doi.org\/10.1152\/ajpheart.00831.2015.","journal-title":"Am J physiol Heart Circ Physiol"},{"key":"1964_CR88","doi-asserted-by":"publisher","first-page":"101682","DOI":"10.1016\/j.arr.2022.101682","volume":"80","author":"W Chen","year":"2022","unstructured":"Chen W, You W, Valencak TG, Shan T. Bidirectional roles of skeletal muscle fibro-adipogenic progenitors in homeostasis and disease. Ageing Res Rev. 2022;80:101682. https:\/\/doi.org\/10.1016\/j.arr.2022.101682.","journal-title":"Ageing Res Rev"},{"key":"1964_CR89","doi-asserted-by":"publisher","unstructured":"Faverio P, Fumagalli A, Conti S, Madotto F, Bini F, Harari S, et al. Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study. ERJ Open Res. 2022;8.https:\/\/doi.org\/10.1183\/23120541.00443-2021.","DOI":"10.1183\/23120541.00443-2021"},{"key":"1964_CR90","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1016\/j.clnu.2021.03.009","volume":"40","author":"KW Kim","year":"2021","unstructured":"Kim KW, Baek MO, Yoon MS, Son KH. Deterioration of mitochondrial function in the human intercostal muscles differs among individuals with sarcopenia, obesity, and sarcopenic obesity. Clin Nutr (Edinburgh, Scotland). 2021;40:2697\u2013706. https:\/\/doi.org\/10.1016\/j.clnu.2021.03.009.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"key":"1964_CR91","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00223-019-00623-z","volume":"106","author":"SE Lee","year":"2020","unstructured":"Lee SE, Park JH, Kim KA, Kang YS, Choi HS. Association between sarcopenic obesity and pulmonary function in Korean elderly: results from the Korean National Health and nutrition examination survey. Calcified Tissue Int. 2020;106:124\u201330. https:\/\/doi.org\/10.1007\/s00223-019-00623-z.","journal-title":"Calcified Tissue Int"},{"key":"1964_CR92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12931-021-01851-4","volume":"22","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, et al. Hospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021;22:257. https:\/\/doi.org\/10.1186\/s12931-021-01851-4.","journal-title":"Respir Res"},{"key":"1964_CR93","doi-asserted-by":"publisher","unstructured":"Pugashetti J, Graham J, Boctor N, Mendez C, Foster E, Juarez M, et al. Weight loss as a predictor of mortality in patients with interstitial lung disease. Eur Respir J. 2018;52.https:\/\/doi.org\/10.1183\/13993003.01289-2018.","DOI":"10.1183\/13993003.01289-2018"},{"key":"1964_CR94","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcsm.12956","volume":"13","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yoon YC, Kim HS, Cha MJ, Kim JH, Kim K, et al. Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia Sarcopenia Muscle. 2022;13:1076\u201386. https:\/\/doi.org\/10.1002\/jcsm.12956.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1964_CR95","doi-asserted-by":"publisher","first-page":"e13534","DOI":"10.1111\/obr.13534","volume":"24","author":"C Liu","year":"2023","unstructured":"Liu C, Wong PY, Chung YL, Chow SK, Cheung WH, Law SW, et al. Deciphering the \u201cobesity paradox\u201d in the elderly: a systematic review and meta-analysis of sarcopenic obesity. Obes Rev. 2023;24:e13534. https:\/\/doi.org\/10.1111\/obr.13534.","journal-title":"Obes Rev"},{"key":"1964_CR96","doi-asserted-by":"publisher","unstructured":"Jouneau S, Lederlin M, Vernhet L, Thibault R. Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity! Eur Respir J. 2019;53.https:\/\/doi.org\/10.1183\/13993003.00418-2019.","DOI":"10.1183\/13993003.00418-2019"},{"key":"1964_CR97","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12931-020-01599-3","volume":"22","author":"S He","year":"2021","unstructured":"He S, Yang J, Li X, Gu H, Su Q, Qin L. Visceral adiposity index is associated with lung function impairment: a population-based study. Respir Res. 2021;22:2. https:\/\/doi.org\/10.1186\/s12931-020-01599-3.","journal-title":"Respir Res"},{"key":"1964_CR98","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12931-022-02159-7","volume":"23","author":"P Faverio","year":"2022","unstructured":"Faverio P, Fumagalli A, Conti S, Madotto F, Bini F, Harari S, et al. Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach. Respir Res. 2022;23:228. https:\/\/doi.org\/10.1186\/s12931-022-02159-7.","journal-title":"Respir Res"},{"key":"1964_CR99","doi-asserted-by":"publisher","first-page":"147997312211172","DOI":"10.1177\/14799731221117298","volume":"19","author":"K Fujita","year":"2022","unstructured":"Fujita K, Ohkubo H, Nakano A, Mori Y, Fukumitsu K, Fukuda S, et al. Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis. Chronic Respir Dis. 2022;19:14799731221117298. https:\/\/doi.org\/10.1177\/14799731221117298.","journal-title":"Chronic Respir Dis"},{"key":"1964_CR100","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/thoraxjnl-2021-218440","volume":"78","author":"A Chandel","year":"2023","unstructured":"Chandel A, Pastre J, Valery S, King CS, Nathan SD. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis. Thorax. 2023;78:368\u201375. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-218440.","journal-title":"Thorax"},{"key":"1964_CR101","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1183\/09031936.00152609","volume":"36","author":"O Nishiyama","year":"2010","unstructured":"Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010;36:1067\u201372. https:\/\/doi.org\/10.1183\/09031936.00152609.","journal-title":"Eur Respir J"},{"key":"1964_CR102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12931-019-1001-6","volume":"20","author":"SW Moon","year":"2019","unstructured":"Moon SW, Choi JS, Lee SH, Jung KS, Jung JY, Kang YA, et al. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients. Respir Res. 2019;20:35. https:\/\/doi.org\/10.1186\/s12931-019-1001-6.","journal-title":"Respir Res"},{"key":"1964_CR103","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/s41598-020-59100-5","volume":"10","author":"A Nakano","year":"2020","unstructured":"Nakano A, Ohkubo H, Taniguchi H, Kondoh Y, Matsuda T, Yagi M, et al. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis. Sci Rep. 2020;10:2312. https:\/\/doi.org\/10.1038\/s41598-020-59100-5.","journal-title":"Sci Rep"},{"key":"1964_CR104","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.21037\/jtd.2019.12.27","volume":"12","author":"M Hanada","year":"2020","unstructured":"Hanada M, Kasawara KT, Mathur S, Rozenberg D, Kozu R, Hassan SA, et al. Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis. J Thorac Dis. 2020;12:1041\u201355. https:\/\/doi.org\/10.21037\/jtd.2019.12.27.","journal-title":"J Thorac Dis"},{"key":"1964_CR105","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000367899","volume":"88","author":"B Vainshelboim","year":"2014","unstructured":"Vainshelboim B, Oliveira J, Yehoshua L, Weiss I, Fox BD, Fruchter O, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respir Int Rev Thorac Dis. 2014;88:378\u201388. https:\/\/doi.org\/10.1159\/000367899.","journal-title":"Respir Int Rev Thorac Dis"},{"key":"1964_CR106","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1378\/chest.11-0258","volume":"140","author":"DA Hickson","year":"2011","unstructured":"Hickson DA, Liu J, Bidulescu A, Burchfiel CM, Taylor HA, Petrini MF. Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: the Jackson Heart Study. Chest. 2011;140:1567\u201373. https:\/\/doi.org\/10.1378\/chest.11-0258.","journal-title":"Chest"},{"key":"1964_CR107","doi-asserted-by":"publisher","unstructured":"Palma G, Sorice GP, Genchi VA, Giordano F, Caccioppoli C, D'Oria R, et al. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. Int J Mol Sci. 2022;23.https:\/\/doi.org\/10.3390\/ijms23137349.","DOI":"10.3390\/ijms23137349"},{"key":"1964_CR108","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cyto.2017.08.019","volume":"102","author":"SA Papiris","year":"2018","unstructured":"Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, et al. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. 2018;102:168\u201372. https:\/\/doi.org\/10.1016\/j.cyto.2017.08.019.","journal-title":"Cytokine"},{"key":"1964_CR109","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/resp.12862","volume":"21","author":"T Arai","year":"2016","unstructured":"Arai T, Kagawa T, Sasaki Y, Sugawara R, Sugimoto C, Tachibana K, et al. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia. Respirology (Carlton, Vic). 2016;21:1431\u20137. https:\/\/doi.org\/10.1111\/resp.12862.","journal-title":"Respirology (Carlton, Vic)"},{"key":"1964_CR110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12931-019-1043-9","volume":"20","author":"L Snyder","year":"2019","unstructured":"Snyder L, Neely ML, Hellkamp AS, O\u2019Brien E, de Andrade J, Conoscenti CS, et al. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Respir Res. 2019;20:105. https:\/\/doi.org\/10.1186\/s12931-019-1043-9.","journal-title":"Respir Res."},{"key":"1964_CR111","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1007\/s00423-022-02549-x","volume":"407","author":"A Umemura","year":"2022","unstructured":"Umemura A, Sasaki A, Nikai H, Yanari S, Ishioka H, Takahashi N, et al. Improvements of lung volumes and respiratory symptoms after weight loss through laparoscopic sleeve gastrectomy. Langenbeck\u2019s Arch Surg. 2022;407:2747\u201354. https:\/\/doi.org\/10.1007\/s00423-022-02549-x.","journal-title":"Langenbeck's Arch Surg."},{"key":"1964_CR112","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek NS, Kuchel GA, Kirkland JL, Xu M. Strategies for targeting senescent cells in human disease. Nature Aging. 2021;1:870\u20139. https:\/\/doi.org\/10.1038\/s43587-021-00121-8.","journal-title":"Nature Aging"},{"key":"1964_CR113","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24:1246\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0092-9.","journal-title":"Nat Med."},{"key":"1964_CR114","doi-asserted-by":"publisher","first-page":"104481","DOI":"10.1016\/j.ebiom.2023.104481","volume":"90","author":"A Nambiar","year":"2023","unstructured":"Nambiar A, Kellogg D 3rd, Justice J, Goros M, Gelfond J, Pascual R, et al. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and\u00a0tolerability. eBioMedicine. 2023;90:104481. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104481.","journal-title":"eBioMedicine"},{"key":"1964_CR115","doi-asserted-by":"publisher","unstructured":"Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, et al. The added value of comorbidities in\u00a0predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study. European Respir J. 2019;53.https:\/\/doi.org\/10.1183\/13993003.01587-2018.","DOI":"10.1183\/13993003.01587-2018"},{"key":"1964_CR116","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46:1113\u201330. https:\/\/doi.org\/10.1183\/13993003.02316-2014.","journal-title":"Eur Respir J"},{"key":"1964_CR117","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12890-019-0951-2","volume":"19","author":"SW Moon","year":"2019","unstructured":"Moon SW, Park MS, Kim YS, Jang J, Lee JH, Lee CT, et al. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation. BMC Pulmonary Med. 2019;19:177. https:\/\/doi.org\/10.1186\/s12890-019-0951-2.","journal-title":"BMC Pulmonary Med."},{"key":"1964_CR118","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12931-020-01545-3","volume":"21","author":"M Nemoto","year":"2020","unstructured":"Nemoto M, Nei Y, Bartholmai B, Yoshida K, Matsui H, Nakashita T, et al. Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study. Respir Res. 2020;21:275. https:\/\/doi.org\/10.1186\/s12931-020-01545-3.","journal-title":"Respir Res"},{"key":"1964_CR119","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.21037\/jtd.2018.03.46","volume":"10","author":"CY Kim","year":"2018","unstructured":"Kim CY, Park JE, Leem AY, Song JH, Kim SY, Chung KS, et al. Prognostic value of pre-transplant mean pulmonary arterial pressure in lung transplant recipients: a single-institution experience. J Thorac Dis. 2018;10:1578\u201387.","journal-title":"J Thorac Dis"},{"key":"1964_CR120","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12931-022-02033-6","volume":"23","author":"DM Jovanovic","year":"2022","unstructured":"Jovanovic DM, \u0160terclov\u00e1 M, Mogulkoc N, Lewandowska K, M\u00fcller V, H\u00e1jkov\u00e1 M, et al. Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study. Respiry Res. 2022;23:135. https:\/\/doi.org\/10.1186\/s12931-022-02033-6.","journal-title":"Respiry Res"},{"key":"1964_CR121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00125-017-4409-x","volume":"61","author":"SC Tang","year":"2018","unstructured":"Tang SC, Baeyens L, Shen CN, Peng SJ, Chien HJ, Scheel DW, et al. Human pancreatic neuro-insular network in health and fatty infiltration. Diabetologia. 2018;61:168\u201381. https:\/\/doi.org\/10.1007\/s00125-017-4409-x.","journal-title":"Diabetologia"},{"key":"1964_CR122","doi-asserted-by":"publisher","unstructured":"Horii T, Fujita Y, Ishibashi C, Fukui K, Eguchi H, Kozawa J, et al. Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes. BMJ Open Diabetes Res Care. 2020;8.https:\/\/doi.org\/10.1136\/bmjdrc-2020-001508.","DOI":"10.1136\/bmjdrc-2020-001508"},{"key":"1964_CR123","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.rmed.2009.08.013","volume":"104","author":"MC Garc\u00eda-Sancho Figueroa","year":"2010","unstructured":"Garc\u00eda-Sancho Figueroa MC, Carrillo G, P\u00e9rez-Padilla R, Fern\u00e1ndez-Plata MR, Buend\u00eda-Rold\u00e1n I, Vargas MH, et al. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study. Respir Med. 2010;104:305\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2009.08.013.","journal-title":"Respir Med"},{"key":"1964_CR124","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1210\/clinem\/dgab553","volume":"106","author":"C Li","year":"2021","unstructured":"Li C, Xiao Y, Hu J, Hu Z, Yan J, Zhou Z, et al. Associations between diabetes and idiopathic pulmonary fibrosis: a study-level pooled analysis of 26 million people. J Clin Endocrino Metab. 2021;106:3367\u201380. https:\/\/doi.org\/10.1210\/clinem\/dgab553.","journal-title":"J Clin Endocrino Metab"},{"key":"1964_CR125","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12931-021-01760-6","volume":"22","author":"L Bai","year":"2021","unstructured":"Bai L, Zhang L, Pan T, Wang W, Wang D, Turner C, et al. Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review. Respir Res. 2021;22:175. https:\/\/doi.org\/10.1186\/s12931-021-01760-6.","journal-title":"Respir Res."},{"key":"1964_CR126","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.rmed.2014.01.008","volume":"108","author":"C Hyldgaard","year":"2014","unstructured":"Hyldgaard C, Hilberg O, Bendstrup E. How does comorbidity influence survival in idiopathic pulmonary fibrosis? Respir Med. 2014;108:647\u201353. https:\/\/doi.org\/10.1016\/j.rmed.2014.01.008.","journal-title":"Respir Med"},{"key":"1964_CR127","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1152\/ajpregu.00316.2020","volume":"321","author":"JL Ather","year":"2021","unstructured":"Ather JL, Van Der Vliet KE, Mank MM, Reed LF, Dixon AE, Poynter ME. Obese adipose tissue modulates proinflammatory responses of mouse airway epithelial cells. Am J Physiol Regul Integr Comp Physiol. 2021;321:R79-r90. https:\/\/doi.org\/10.1152\/ajpregu.00316.2020.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1964_CR128","doi-asserted-by":"publisher","first-page":"585989","DOI":"10.1155\/2010\/585989","volume":"2010","author":"R Tkacova","year":"2010","unstructured":"Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspective. Mediat Inflamm. 2010;2010:585989. https:\/\/doi.org\/10.1155\/2010\/585989.","journal-title":"Mediat Inflamm"},{"key":"1964_CR129","doi-asserted-by":"publisher","first-page":"585693","DOI":"10.3389\/fnut.2020.585693","volume":"7","author":"J Spielmann","year":"2020","unstructured":"Spielmann J, Naujoks W, Emde M, Allweyer M, Kielstein H, Quandt D, et al. High-Fat Diet and Feeding Regime Impairs Number, Phenotype, and Cytotoxicity of Natural Killer Cells in C57BL\/6 Mice. Front Nutr. 2020;7:585693. https:\/\/doi.org\/10.3389\/fnut.2020.585693.","journal-title":"Front Nutr"},{"key":"1964_CR130","doi-asserted-by":"publisher","first-page":"729182","DOI":"10.3389\/fimmu.2021.729182","volume":"12","author":"JCR de Jesus","year":"2021","unstructured":"de Jesus JCR, Murari ASP, Radloff K, de Moraes RCM, Figuer\u00eado RG, Pessoa AFM, et al. Activation of the adipose tissue NLRP3 inflammasome pathway in cancer cachexia. Fronti Immunol. 2021;12:729182. https:\/\/doi.org\/10.3389\/fimmu.2021.729182.","journal-title":"Fronti Immunol"},{"key":"1964_CR131","doi-asserted-by":"publisher","unstructured":"El-Horany HE, Atef MM, Abdel Ghafar MT, Fouda MH, Nasef NA, Hegab, II, et al. Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2\/AMPK\/Nrf2 Signaling and Targeting Ferroptosis and Autophagy. Int J Mol Sci. 2023;24.https:\/\/doi.org\/10.3390\/ijms24119481.","DOI":"10.3390\/ijms24119481"},{"key":"1964_CR132","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1038\/s41598-020-74912-1","volume":"10","author":"J Fandi\u00f1o","year":"2020","unstructured":"Fandi\u00f1o J, Toba L, Gonz\u00e1lez-Mat\u00edas LC, Diz-Chaves Y, Mallo F. GLP-1 receptor agonist ameliorates experimental lung fibrosis. Sci Rep. 2020;10:18091. https:\/\/doi.org\/10.1038\/s41598-020-74912-1.","journal-title":"Sci Rep"},{"key":"1964_CR133","doi-asserted-by":"publisher","first-page":"1089812","DOI":"10.3389\/fphar.2023.1089812","volume":"14","author":"H Ji","year":"2023","unstructured":"Ji H, Dong H, Lan Y, Bi Y, Gu X, Han Y, et al. Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis. Front Pharmacol. 2023;14:1089812. https:\/\/doi.org\/10.3389\/fphar.2023.1089812.","journal-title":"Front Pharmacol"},{"key":"1964_CR134","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2019.02.037","volume":"851","author":"H Zhang","year":"2019","unstructured":"Zhang H, You L, Zhao M. Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner. Eur J Pharmacol. 2019;851:133\u201343. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.037.","journal-title":"Eur J Pharmacol"},{"key":"1964_CR135","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2012.05.026","volume":"689","author":"M Samah","year":"2012","unstructured":"Samah M, El-Aidy Ael R, Tawfik MK, Ewais MM. Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol. 2012;689:186\u201393. https:\/\/doi.org\/10.1016\/j.ejphar.2012.05.026.","journal-title":"Eur J Pharmacol"},{"key":"1964_CR136","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1440-1681.2010.05431.x","volume":"37","author":"JW Kim","year":"2010","unstructured":"Kim JW, Rhee CK, Kim TJ, Kim YH, Lee SH, Yoon HK, et al. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. Clin Exp Pharmacol Physiol. 2010;37:1055\u201363. https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05431.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1964_CR137","doi-asserted-by":"publisher","first-page":"e23074","DOI":"10.1002\/jbt.23074","volume":"36","author":"M Yildirim","year":"2022","unstructured":"Yildirim M, Kayalar O, Atahan E, Oztay F. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis. J Biochem Mol Toxicol. 2022;36:e23074. https:\/\/doi.org\/10.1002\/jbt.23074.","journal-title":"J Biochem Mol Toxicol"},{"key":"1964_CR138","doi-asserted-by":"publisher","first-page":"1039707","DOI":"10.3389\/fmed.2022.1039707","volume":"9","author":"P Seenak","year":"2022","unstructured":"Seenak P, Kumphune S, Prasitsak T, Nernpermpisooth N, Malakul W. Atorvastatin and ezetimibe protect against hypercholesterolemia-induced lung oxidative stress, inflammation, and fibrosis in rats. Front Med. 2022;9:1039707. https:\/\/doi.org\/10.3389\/fmed.2022.1039707.","journal-title":"Front Med"},{"key":"1964_CR139","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.pupt.2019.101803","volume":"57","author":"HX Zhang","year":"2019","unstructured":"Zhang HX, Li YN, Wang XL, Ye CL, Zhu XY, Li HP, et al. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression. Pulmonary PharmacolTher. 2019;57:101803. https:\/\/doi.org\/10.1016\/j.pupt.2019.101803.","journal-title":"Pulmonary PharmacolTher"},{"key":"1964_CR140","doi-asserted-by":"publisher","unstructured":"Gomez-Manjarres DC, Axell-House DB, Patel DC, Odackal J, Yu V, Burdick MD, et al. Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial. JCI Insight. 2023;8.https:\/\/doi.org\/10.1172\/jci.insight.166901.","DOI":"10.1172\/jci.insight.166901"},{"key":"1964_CR141","doi-asserted-by":"publisher","unstructured":"Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, et al. A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019;53.https:\/\/doi.org\/10.1183\/13993003.01992-2018.","DOI":"10.1183\/13993003.01992-2018"},{"key":"1964_CR142","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","volume":"154","author":"SM Palmer","year":"2018","unstructured":"Palmer SM, Snyder L, Todd JL, Soule B, Christian R, Anstrom K, et al. Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. Chest. 2018;154:1061\u20139. https:\/\/doi.org\/10.1016\/j.chest.2018.08.1058.","journal-title":"Chest"},{"key":"1964_CR143","doi-asserted-by":"publisher","unstructured":"Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, et al. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res. 2021;8.https:\/\/doi.org\/10.1136\/bmjresp-2021-001026.","DOI":"10.1136\/bmjresp-2021-001026"},{"key":"1964_CR144","doi-asserted-by":"publisher","first-page":"e000422","DOI":"10.1136\/bmjresp-2019-000422","volume":"6","author":"TM Maher","year":"2019","unstructured":"Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, et al. Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). BMJ Open Respir Res. 2019;6:e000422. https:\/\/doi.org\/10.1136\/bmjresp-2019-000422.","journal-title":"BMJ Open Respir Res"},{"key":"1964_CR145","doi-asserted-by":"publisher","unstructured":"Khalil N, Manganas H, Ryerson CJ, Shapera S, Cantin AM, Hernandez P, et al. Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis. Eur Respir Jo. 2019;53.https:\/\/doi.org\/10.1183\/13993003.00663-2018.","DOI":"10.1183\/13993003.00663-2018"},{"key":"1964_CR146","doi-asserted-by":"publisher","unstructured":"Strambu IR, Seemayer CA, Fagard LMA, Ford PA, Van der Aa TAK, de Haas-Amatsaleh AA, et al. GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial. Eur Respir J. 2023;61.https:\/\/doi.org\/10.1183\/13993003.01794-2022.","DOI":"10.1183\/13993003.01794-2022"},{"key":"1964_CR147","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nm1685","volume":"14","author":"AM Tager","year":"2008","unstructured":"Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med. 2008;14:45\u201354. https:\/\/doi.org\/10.1038\/nm1685.","journal-title":"Nat Med"},{"key":"1964_CR148","doi-asserted-by":"publisher","first-page":"15549","DOI":"10.1021\/acs.jmedchem.1c01256","volume":"64","author":"PTW Cheng","year":"2021","unstructured":"Cheng PTW, Kaltenbach RF 3rd, Zhang H, Shi J, Tao S, Li J, et al. Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA(1)) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases. J Med Chem. 2021;64:15549\u201381. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01256.","journal-title":"J Med Chem"},{"key":"1964_CR149","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/labinvest.2016.145","volume":"97","author":"X Liu","year":"2017","unstructured":"Liu X, Wong SS, Taype CA, Kim J, Shentu TP, Espinoza CR, et al. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution. Lab Investig. 2017;97:256\u201367. https:\/\/doi.org\/10.1038\/labinvest.2016.145.","journal-title":"Lab Investig"},{"key":"1964_CR150","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jbior.2014.09.008","volume":"57","author":"LS Huang","year":"2015","unstructured":"Huang LS, Natarajan V. Sphingolipids in pulmonary fibrosis. Adv Biol Regul. 2015;57:55\u201363. https:\/\/doi.org\/10.1016\/j.jbior.2014.09.008.","journal-title":"Adv Biol Regul."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01964-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:05:01Z","timestamp":1700798701000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01964-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01964-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals.performed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}